1. Home
  2. CVEO vs ESPR Comparison

CVEO vs ESPR Comparison

Compare CVEO & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVEO
  • ESPR
  • Stock Information
  • Founded
  • CVEO 1977
  • ESPR 2008
  • Country
  • CVEO United States
  • ESPR United States
  • Employees
  • CVEO N/A
  • ESPR N/A
  • Industry
  • CVEO Hotels/Resorts
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • CVEO Consumer Discretionary
  • ESPR Health Care
  • Exchange
  • CVEO Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • CVEO 342.5M
  • ESPR 410.2M
  • IPO Year
  • CVEO N/A
  • ESPR 2013
  • Fundamental
  • Price
  • CVEO $27.28
  • ESPR $1.82
  • Analyst Decision
  • CVEO Strong Buy
  • ESPR Buy
  • Analyst Count
  • CVEO 1
  • ESPR 6
  • Target Price
  • CVEO $32.00
  • ESPR $7.25
  • AVG Volume (30 Days)
  • CVEO 148.9K
  • ESPR 3.4M
  • Earning Date
  • CVEO 03-03-2025
  • ESPR 03-04-2025
  • Dividend Yield
  • CVEO 3.66%
  • ESPR N/A
  • EPS Growth
  • CVEO N/A
  • ESPR N/A
  • EPS
  • CVEO 1.44
  • ESPR N/A
  • Revenue
  • CVEO $701,970,000.00
  • ESPR $295,451,000.00
  • Revenue This Year
  • CVEO $0.97
  • ESPR $186.86
  • Revenue Next Year
  • CVEO $3.72
  • ESPR $9.41
  • P/E Ratio
  • CVEO $18.91
  • ESPR N/A
  • Revenue Growth
  • CVEO 1.41
  • ESPR 187.12
  • 52 Week Low
  • CVEO $21.15
  • ESPR $1.58
  • 52 Week High
  • CVEO $28.92
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • CVEO 78.14
  • ESPR 38.40
  • Support Level
  • CVEO $24.56
  • ESPR $1.82
  • Resistance Level
  • CVEO $27.55
  • ESPR $1.91
  • Average True Range (ATR)
  • CVEO 0.78
  • ESPR 0.09
  • MACD
  • CVEO 0.35
  • ESPR 0.02
  • Stochastic Oscillator
  • CVEO 94.19
  • ESPR 47.83

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia and the United States. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, Australia and the United States.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: